Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Gel with Tadalafil for ED Non-Responders
NCT00244023Phase 3Completed
- Sponsor
- SELARL du Dr Jacques Buvat
- Start
- Oct 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Testosterone TEPI patch in erectile dysfunction (ED), sponsored by SELARL du Dr Jacques Buvat. Primary endpoint: Erectile Function Domain Score of the International Index of Erectile Function at 12 weeks. Started Oct 2005; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00244023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244023.